CART19 therapy

CD19-targeted chimeric antigen receptor T-cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CART19 therapy, covering 2016-01-28 to 2016-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]